Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	89.36	71.29	119.71	209.95	684.64	113.94
Short-Term Investments	644.82	639.36	825.28	267.17	187.21	369.62
Cash & Short-Term Investments	734.17	710.64	944.99	477.11	871.85	483.55
Cash Growth	2.97%	-24.80%	98.06%	-45.28%	80.30%	-2.12%
Receivables	65.81	43.18	36.94	37.03	25.31	23.41
Inventory	12.53	21.22	29.7	21.82	8.58	-
Prepaid Expenses	42.33	33.35	35.02	18.06	22.02	9.32
Restricted Cash	-	-	-	-	-	0.5
Total Current Assets	854.85	808.39	1,047	554.03	927.76	516.79
Property, Plant & Equipment	104.27	115.65	115.2	120.86	101.67	111.11
Long-Term Investments	176.88	84.32	161.27	557.53	677.87	64.41
Other Long-Term Assets	63.66	40.89	26.78	19.81	11.09	15.39
Total Assets	1,200	1,049	1,350	1,252	1,718	707.69
Accounts Payable	4.72	4.71	2.73	8.33	4.37	4.79
Accrued Expenses	99.71	110.53	122.08	117.9	104.97	88.71
Current Portion of Long-Term Debt	104.94	69.48	34.14	-	-	-
Current Portion of Leases	13.01	11.93	10.58	8.09	7.94	6.82
Current Unearned Revenue	4.12	0.81	4.67	11.51	12.56	6.16
Other Current Liabilities	31.18	17.47	9.05	3.93	0.97	-
Total Current Liabilities	257.66	214.92	183.23	149.77	130.8	106.48
Long-Term Debt	542.84	610.96	535.28	-	-	-
Long-Term Leases	71.92	81.75	92.79	103.32	81.67	89.13
Long-Term Unearned Revenue	7.92	4.79	13.62	25.07	28.6	39.91
Other Long-Term Liabilities	6.17	6.21	10.3	3.34	7.24	7.81
Total Liabilities	886.5	918.64	835.23	281.49	248.31	243.34
Common Stock	0.06	0.06	0.06	0.06	0.06	0.05
Additional Paid-In Capital	2,671	2,474	2,358	2,250	2,107	1,412
Retained Earnings	-2,357	-2,340	-1,833	-1,275	-631.36	-945.24
Comprehensive Income & Other	-1.07	-3.5	-10.44	-4.13	-5.21	-2.54
Total Common Equity	313.15	130.61	514.68	970.74	1,470	464.36
Shareholders' Equity	313.15	130.61	514.68	970.74	1,470	464.36
Total Liabilities & Equity	1,200	1,049	1,350	1,252	1,718	707.69
Total Debt	732.7	774.12	672.78	111.41	89.6	95.95
Net Cash (Debt)	149.65	-6.95	405.69	923.24	1,460	452.01
Net Cash Growth	182.10%	-	-56.06%	-36.77%	223.03%	-8.50%
Net Cash Per Share	2.41	-0.11	6.80	15.78	26.00	9.45
Filing Date Shares Outstanding	63.53	61.23	59.98	59.2	57.96	54.03
Total Common Shares Outstanding	63.45	61.15	59.96	59.14	57.79	49.27
Working Capital	597.19	593.47	863.42	404.26	796.96	410.3
Book Value Per Share	4.93	2.14	8.58	16.41	25.44	9.42
Tangible Book Value	313.15	130.61	514.68	970.74	1,470	464.36
Tangible Book Value Per Share	4.93	2.14	8.58	16.41	25.44	9.42
Machinery	-	27.98	21.32	18.55	16.35	14.05
Construction In Progress	-	9.51	1.61	0.21	0.15	0.96
Leasehold Improvements	-	42.3	41.05	36.95	36.95	36.63

Source: S&P Capital IQ. Standard template. Financial Sources.